Portland, OR -- (SBWIRE) -- 10/05/2017 -- The medical contrast agent is a material used in medical imaging to improve the contrast of structure or fluids inside a body. The contrast agents provide enhanced visibility for observation of blood vessels and the gastrointestinal tract. According to the imaging modalities such as x-ray and ultrasound, an array of contrast reagents is used as per requirement of the imaging technique.
The Medical Contrast Agent Market is driven by growth in approval of contrast agents and increase in number of private diagnostics clinics & services. Moreover, technological development in diagnostics imaging and strong product pipeline of market players are expected to boost the market growth. However, high cost of medical imaging equipment and lack of skilled professionals in the industry may impede this growth.
The global medical contrast agent market is segmented based on type, procedure, route of administration, indication, application, and region. Based on type, it is classified into barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, and microbubble contrast media. Based on the procedure, it is segmented into X-ray/computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Based on the route of administration, it is categorized into oral contrast media, injectable contrast media, rectal contrast media, and urethral contrast media.
Exclusive Offer !!! Get Flat 20% discount on this report
Medical Contrast Agent Market Key Segments:
-Barium-based Contrast Media
-Iodinated Contrast Media
-Gadolinium-based Contrast Media
-Microbubble Contrast Media
-X-ray/Computed Tomography (CT)
-Magnetic Resonance Imaging (MRI)
By Route of Administration
-Oral Contrast Media
-Injectable Contrast Media
-Rectal Contrast Media
-Urethral Contrast Media
To request a sample copy of this report, click the link : https://www.alliedmarketresearch.com/request-toc-and-sample/4367
Comprehensive competitive analysis and profiles of major players, such as GE Healthcare, Bayer AG, Bracco Imaging S.P.A., Guerbet Group, Lantheus Medical Imaging, Nanopet Pharma GmbH, CMC Contrast AB, Daiichi Sankyo, Subhra Pharma Private Limited, and Spago Nanomedical AB, are provided in this report.